Largest genetic study on stroke to date improves risk prediction

• A group of investigators from the Research Institute of the Hospital de la Santa Creu i Sant Pau - IIB Sant Pau has led the analysis of Spanish data from the largest international study carried out to date on the genetics of stroke risk.
• The results, published by the prestigious journal Nature, allow us to predict, with much more precision, the risk that a person may suffer a stroke. In addition, they provide valuable information on the biological processes involved in this disease, which is helping to find new, more effective treatments.
• The study analyzed data from the International Stroke Genetics Consortium, of which the Spanish Genestroke consortium is a member, and the GCAT|Genomes for Life cohort, from the Germans Trias i Pujol Research Institute (IGTP).

COVID-19: One in three infected but unvaccinated persons no longer have detectable antibodies one year after the infection

A seroprevalence analysis, conducted on 1,076 people aged 43-72 years, finds that vaccine type, age, and mental health are factors strongly associated with levels of vaccine-induced antibodies.

END-VOC Kicks Off with the Aim of Supporting the Global Response to COVID-19 and Future Pandemics

The European project aims to evaluate the circulation and impact of emerging SARS-CoV-2 variants of concern through the study of well-characterised cohorts across the world

Sugars steer stem cell extracellular vesicles to epithelial cells

Researchers at the Germans Trias i Pujol Research Institute (IGTP) discover new facets of the biology of extra-cellular vesicles that will advance their use in therapies. In an article published in the International Journal of Molecular Sciences they describe the importance of glycosylation for the interactions between extracellular vesicles from mesenchymal stem cells and endothelial cells.

GCAT contributes to identify a new genetic region linked with the severity of COVID-19 and to extensively characterize a chromosomal inversion

The Severe Covid-19 GWAS Group, the group that reported the first genetic analysis in early pandemic (NEJM, 2020), presents now the new results of an extended GWAS meta-analysis of a well-characterized cohort of 3,260 COVID-19 patients with respiratory failure and 12,483 population controls from Italy, Spain, Norway and Germany/Austria, that have been published in Human Molecular Genetics.

Study identifies 11 new genetic regions linked with the susceptibility and severity of COVID-19

An international macro-study in which researchers from the GCAT|Genomes for Life project of the Germans Trias i Pujol Research Institute (IGTP) have participated has located 11 new chromosomal regions involved in susceptibility to SARS-CoV-2 infection and in severity COVID-19 clinic. The work is published in the journal Nature.

A community-based intervention for the micro-elimination of hepatitis C in the Pakistani population in Catalonia

Since 2019, around 1,000 immigrants from endemic countries have participated in a new model of diagnosis and management of viral hepatitis that has been designed by the Clinical Virology and New Diagnostic Approaches Research Group of the Germans Trias i Pujol Research Institute (IGTP), in the Microbiology Service of the Germans Trial Hospital (headed by Dr. Elisa Martró), along with the Public and Community Health Team (eSPiC) of Drassanes-Vall d'Hebron International Health Unit.

The IGTP coordinating two out of nine COST Actions coming to Spain and participating in a third

The COST Programme (European Cooperation in Science and Technology) has approved 70 new actions and Spain is coordinating nine of them, making it second in the ranking of countries leading COST Actions after Italy, which is coordinating ten. Three of the Spanish projects are from the Germans Trias i Pujol Research Institute (IGTP) and two of these are being led by the IGTP. COST Actions run for four years and this round will start in the coming autumn.

The 'Survival vs. Resilience' project will turn Badalona into a laboratory of art and science to anticipate the future of society

The of Fundación Épica of La Fura dels Baus Project, in collaboration with the Institut Germans Trias i Pujol and the Barcelona Institute of Science and Technology will take place from 11-24 July at the old CACI factory in Badalona.

Bioimplants with extra-cellular vesicles from stem cells can improve cardiac function after an acute myocardial heart attack

Researchers from the ICREC Group (Cardiac Insufficiency and Regeneration) in cardiovascular diseases at the Germans Trias i Pujol Research Institute (IGTP) continue to work on therapeutic technologies to repair cardiac tissue after a heart attack. In an article published in Theranostics, they present a study of extracellular vesicles from mesenchymal stem cells combined with tissue engineering as a therapy to repair the heart after a heart attack. They have carried out the study on a porcine heart attack model at the Centre for Comparative Medicine and Bioimage (CMCiB) at the IGTP.